Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Calmy

Showing results (121-130 of 415) with videos related to

Pageof 42
Sort By:
AIDS (London, England)|July 11, 2017
Adverse events of raltegravir and dolutegravirLuigia Elzi, Stefan Erb, Hansjakob Furrer, et al.
AIDS (London, England)|July 7, 2022
Clinical decision support systems to guide healthcare providers on HIV testingMikaela Smit, Carlijn C E Jordans, Jitte M Reinhard, et al.
Plos Neglected Tropical Diseases|November 13, 2015
Generating Evidence to Improve the Response to Neglected Diseases: How Operational Research in a Médecins Sans Frontières Buruli Ulcer Treatment Programme Informed International Management GuidanceDaniel P O'Brien, Nathan Ford, Marco Vitoria, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 8, 2018
Managing Advanced HIV Disease in a Public Health ApproachNathan Ford, Graeme Meintjes, Alexandra Calmy, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 23, 2011
Longer term clinical and virological outcome of sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort StudyCornelia Staehelin, Olivia Keiser, Alexandra Calmy, et al.
BMC Pharmacology & Toxicology|September 27, 2023
Population pharmacokinetic analysis of lopinavir in HIV negative individuals exposed to SARS-CoV-2: a COPEP (COronavirus Post-Exposure Prophylaxis) sub-studyPaul Thoueille, Margot Delfraysse, Pascal Andre, et al.
Nature Reviews. Disease Primers|June 20, 2020
HIV and antiretroviral therapy-related fat alterationsJohn R Koethe, Claire Lagathu, Jordan E Lake, et al.
AIDS (London, England)|December 11, 2014
Adherence to HIV postexposure prophylaxis: a systematic review and meta-analysisNathan Ford, Cadi Irvine, Zara Shubber, et al.
British Journal of Clinical Pharmacology|April 27, 2023
Effect of SLCO1B1 c.521T>C polymorphism on the lipid response to statins in people living with HIV on a boosted protease inhibitor-containing regimenCatia Marzolini, Matthias Cavassini, Dominique L Braun, et al.
AIDS (London, England)|January 13, 2022
Long-term effects of evolocumab in participants with HIV and dyslipidemia: results from the open-label extension periodFranck Boccara, Bruno Caramelli, Alexandra Calmy, et al.
Pageof 42

Showing results (121-130 of 415) with videos related to

Sort By:
Pageof 42
AIDS (London, England)|July 11, 2017
Adverse events of raltegravir and dolutegravirLuigia Elzi, Stefan Erb, Hansjakob Furrer, et al.
AIDS (London, England)|July 7, 2022
Clinical decision support systems to guide healthcare providers on HIV testingMikaela Smit, Carlijn C E Jordans, Jitte M Reinhard, et al.
Plos Neglected Tropical Diseases|November 13, 2015
Generating Evidence to Improve the Response to Neglected Diseases: How Operational Research in a Médecins Sans Frontières Buruli Ulcer Treatment Programme Informed International Management GuidanceDaniel P O'Brien, Nathan Ford, Marco Vitoria, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 8, 2018
Managing Advanced HIV Disease in a Public Health ApproachNathan Ford, Graeme Meintjes, Alexandra Calmy, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 23, 2011
Longer term clinical and virological outcome of sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort StudyCornelia Staehelin, Olivia Keiser, Alexandra Calmy, et al.
BMC Pharmacology & Toxicology|September 27, 2023
Population pharmacokinetic analysis of lopinavir in HIV negative individuals exposed to SARS-CoV-2: a COPEP (COronavirus Post-Exposure Prophylaxis) sub-studyPaul Thoueille, Margot Delfraysse, Pascal Andre, et al.
Nature Reviews. Disease Primers|June 20, 2020
HIV and antiretroviral therapy-related fat alterationsJohn R Koethe, Claire Lagathu, Jordan E Lake, et al.
AIDS (London, England)|December 11, 2014
Adherence to HIV postexposure prophylaxis: a systematic review and meta-analysisNathan Ford, Cadi Irvine, Zara Shubber, et al.
British Journal of Clinical Pharmacology|April 27, 2023
Effect of SLCO1B1 c.521T>C polymorphism on the lipid response to statins in people living with HIV on a boosted protease inhibitor-containing regimenCatia Marzolini, Matthias Cavassini, Dominique L Braun, et al.
AIDS (London, England)|January 13, 2022
Long-term effects of evolocumab in participants with HIV and dyslipidemia: results from the open-label extension periodFranck Boccara, Bruno Caramelli, Alexandra Calmy, et al.
Pageof 42